Back
Petros Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
37
PTPI
Petros Pharmaceuticals
Last Price:
0.35
Seasonality Move:
-0.39%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-19.92%
Sell
37
Petros Pharmaceuticals (PTPI)
is a Sell
Is Petros Pharmaceuticals a Buy, Sell or Hold?
- The current Petros Pharmaceuticals [PTPI] share price is $0.36. The Score for PTPI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PTPI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTPI Stock Price Chart
What is Petros Pharmaceuticals's stock price today?
-
The Petros Pharmaceuticals share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTPI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
PTPI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.82 | Sell |
Chaikin Money Flow: | -11978 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.33 - 0.37) | Buy |
Bollinger Bands (100): | (0.33 - 0.51) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 55.73 | Buy |
Chaikin Money Flow: | -66635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.46 - 0.7) | Buy |
Bollinger Bands (100): | (0.33 - 3.11) | Sell |
PTPI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.36 | Sell |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 0.82 | Sell |
8-day EMA: | 0.35 | Buy |
20-day EMA: | 0.35 | Buy |
50-day EMA: | 0.38 | Sell |
200-day EMA: | 0.88 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.71 | Buy |
20-day SMA: | 0.61 | Buy |
50-day SMA: | 0.55 | Buy |
200-day SMA: | 3.29 | Sell |
8-day EMA: | 0.7 | Buy |
20-day EMA: | 0.65 | Buy |
50-day EMA: | 0.87 | Sell |
200-day EMA: | 7.55 | Sell |
Petros Pharmaceuticals Earnings Growth & PTPI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Petros Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |